Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-20-000079
Filing Date
2020-07-06
Accepted
2020-07-06 16:52:03
Documents
2
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3556
2 EDGAR SUPPORTING DOCUMENT fanucci_20200701poa.txt EX-24 4091
  Complete submission text file 0001735276-20-000079.txt   9163
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Fanucci Marsha (Reporting) CIK: 0001298814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 201014042